ARTICLE
|
doi:10.20944/preprints202306.0940.v1
Subject:
Medicine And Pharmacology,
Clinical Medicine
Keywords:
18 months; deep molecular response; nilotinib; newly diagnosed; chronic-phase chronic myeloid leukemia
Online: 13 June 2023 (12:52:05 CEST)